These data strongly indicate that SIM2l independently acts as a tumor suppressor gene via suppression of HIF-1α-induced angiogenesis and of hypoxia resistance in CvSCC patients who received radiotherapy (Fig. 5g). Here, HIF1A is linked to neoplasm.